Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 4—April 2026

Research

Accelerated Increase in Candida auris Bloodstream Infections during COVID-19 Pandemic, South Africa

Husna Ismail, Olga Perovic, Ruth Mpembe, Warren Lowman, Chetna Govind, Pieter Ekermans, Waasila Jassat, Richard Welch, and Nelesh P. GovenderComments to Author 
Author affiliation: National Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa (H. Ismail, O. Perovic, R. Mpembe, W. Jassat, R. Welch, N.P. Govender); University of the Witwatersrand, Johannesburg South Africa (R. Mpembe, W. Lowman, N.P. Govender); Vermaak and Partners/Pathcare Pathologists, Pretoria, South Africa (W. Lowman); Wits Donald Gordon Medical Centre, Johannesburg (W. Lowman); Lancet Laboratories, Durban, South Africa (C. Govind); Ampath Microbiology National Reference Laboratory, Centurion, South Africa (P. Ekermans)

Main Article

Figure 3

Total number of cases of Candida BSIs (n = 15,393), COVID-19 cases (n = 3,995,881), and COVID-19 hospital admissions (n = 486,789), by month and 30-day moving average, in study of accelerated increase in C. auris BSIs during COVID-19 pandemic, South Africa, January 2019–June 2022. Numbers are shown for public health sector (A), private health sector (B), and total national (C). Light green bars represent cases of Candida BSI (private, n = 10,826; public, n = 4,567), orange bars represent COVID-19 cases, blue bars represent COVID-19 hospital admissions (private, n = 231,814; public, n = 254,975), and black dotted line represents the 30-day moving average number cases. Scales for the y-axes differ substantially to underscore patterns but do not permit direct comparisons. BSI, bloodstream infection.

Figure 3. Total number of cases of Candida BSIs (n = 15,393), COVID-19 cases (n = 3,995,881), and COVID-19 hospital admissions (n = 486,789), by month and 30-day moving average, in study of accelerated increase in C. auris BSIs during COVID-19 pandemic, South Africa, January 2019–June 2022. Numbers are shown for public health sector (A), private health sector (B), and total national (C). Light green bars represent cases of Candida BSI (private, n = 10,826; public, n = 4,567), orange bars represent COVID-19 cases, blue bars represent COVID-19 hospital admissions (private, n = 231,814; public, n = 254,975), and black dotted line represents the 30-day moving average number cases. Scales for the y-axes differ substantially to underscore patterns but do not permit direct comparisons. BSI, bloodstream infection.

Main Article

Page created: February 07, 2026
Page updated: April 15, 2026
Page reviewed: April 15, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external